Cargando…
Bortezomib-containing regiment in treating glomerulopathy with fibronectin deposits combined with monoclonal gammopathy of undetermined significance: a case report and literature review
BACKGROUND: Glomerulopathy with fibronectin deposits (GFND) is a newly recognized rare glomerular disease. As its onset can be stably inherited in affected families without sex differences and fibronectin 1 (FN1) mutations can be detected in 40% of patients’ families, GFND is considered to be an aut...
Autores principales: | Zhang, Wenjie, Zhang, Qike, Wei, Xiaofang, Feng, Youfan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011310/ https://www.ncbi.nlm.nih.gov/pubmed/35434028 http://dx.doi.org/10.21037/atm-22-242 |
Ejemplares similares
-
Fibronectin glomerulopathy with monoclonal gammopathy responding to bortezomib plus dexamethasone: a case report
por: Li, Xiaoli, et al.
Publicado: (2022) -
Immunophenotypic studies of monoclonal gammopathy of undetermined significance
por: Olteanu, Horatiu, et al.
Publicado: (2008) -
Monoclonal Gammopathy of Undetermined Significance-associated Scleromyxoedema
por: Baxi, Kalgi D., et al.
Publicado: (2019) -
Kidney Transplantation and Monoclonal Gammopathy of Undetermined Significance
por: Aslam, Nabeel, et al.
Publicado: (2021) -
Crystalloid glomerulopathy in monoclonal gammopathy of renal significance (MGRS)
por: Vankalakunti, Mahesha, et al.
Publicado: (2014)